Danaher Corp
NYSE:DHR
Intrinsic Value
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. [ Read More ]
The intrinsic value of one DHR stock under the Base Case scenario is 177.36 USD. Compared to the current market price of 245.92 USD, Danaher Corp is Overvalued by 28%.
Valuation Backtest
Danaher Corp
Run backtest to discover the historical profit from buying and selling DHR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Danaher Corp
Current Assets | 13.9B |
Cash & Short-Term Investments | 5.9B |
Receivables | 4B |
Other Current Assets | 4.1B |
Non-Current Assets | 70.6B |
PP&E | 5.6B |
Intangibles | 62.4B |
Other Non-Current Assets | 2.6B |
Current Liabilities | 8.3B |
Accounts Payable | 1.8B |
Accrued Liabilities | 3.3B |
Other Current Liabilities | 3.2B |
Non-Current Liabilities | 22.7B |
Long-Term Debt | 16.7B |
Other Non-Current Liabilities | 6B |
Earnings Waterfall
Danaher Corp
Revenue
|
23.9B
USD
|
Cost of Revenue
|
-9.9B
USD
|
Gross Profit
|
14B
USD
|
Operating Expenses
|
-8.8B
USD
|
Operating Income
|
5.3B
USD
|
Other Expenses
|
-536m
USD
|
Net Income
|
4.7B
USD
|
Free Cash Flow Analysis
Danaher Corp
DHR Profitability Score
Profitability Due Diligence
Danaher Corp's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
Score
Danaher Corp's profitability score is 59/100. The higher the profitability score, the more profitable the company is.
DHR Solvency Score
Solvency Due Diligence
Danaher Corp's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Danaher Corp's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DHR Price Targets Summary
Danaher Corp
According to Wall Street analysts, the average 1-year price target for DHR is 269.54 USD with a low forecast of 217.15 USD and a high forecast of 304.5 USD.
Ownership
DHR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
DHR Price
Danaher Corp
Average Annual Return | 22.17% |
Standard Deviation of Annual Returns | 28.31% |
Max Drawdown | -44% |
Market Capitalization | 181.7B USD |
Shares Outstanding | 746 100 000 |
Percentage of Shares Shorted | 0.96% |
DHR News
Last Important Events
Danaher Corp
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Danaher Corp
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 78,000 full-time employees. The firm operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.
Contact
IPO
Employees
Officers
The intrinsic value of one DHR stock under the Base Case scenario is 177.36 USD.
Compared to the current market price of 245.92 USD, Danaher Corp is Overvalued by 28%.